Prakash Nagarkatti
Biographic Data
| ID | 7292680 |
|---|---|
| NAME | Prakash Nagarkatti |
| GIVEN NAMES | Prakash |
| FAMILY NAME | Nagarkatti |
| SIGNATURE | NAGARKATTI P |
| AFFILIATIONS | University of South Carolina |
| ORCID | 0000-0003-2663-0759 |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 5 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Geographic inequality in funding by National Institutes of Health negatively impacts almost one-half of the states in the United States
Introduction: The National Institutes of Health (NIH) is the primary federal agency in the United States (US) that supports biomedical research, training, and clinical trials. NIH funding creates patents and jobs and thus helps the regional and national economy grow. Therefore, NIH funding would be expected to flow equitably to all 50 US states. However, there is a significant geographic disparity in the level of NIH funding received by various s…
Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy
American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway
An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes
American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages
No prominent works on this page.
American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages
An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes
American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway
Identifying panaxynol, a natural activator of nuclear factor erythroid-2 related factor 2 (Nrf2) from American ginseng as a suppressor of inflamed macrophage-induced cardiomyocyte hypertrophy
Geographic inequality in funding by National Institutes of Health negatively impacts almost one-half of the states in the United States
Introduction: The National Institutes of Health (NIH) is the primary federal agency in the United States (US) that supports biomedical research, training, and clinical trials. NIH funding creates patents and jobs and thus helps the regional and national economy grow. Therefore, NIH funding would be expected to flow equitably to all 50 US states. However, there is a significant geographic disparity in the level of NIH funding received by various s…
Medicine (5 works) · Biochemistry (4 works) · Biology (4 works) · Ginseng (4 works) · Ginseng Biological Effects and Applications (4 works) · Chemistry (3 works) · Pharmacology (3 works) · Cell Biology (2 works) · Genomics, phytochemicals, and oxidative stress (2 works) · In vitro (2 works)